This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

LATE trial

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

This trial assessed the role of thrombolysis in patients with ECG-diagnosed myocardial infarction who present more than 6 hr after the onset of symptoms.

Thrombolysis up to 12 hr post-onset of symptoms was associated with improved survival.

Reference:

  • LATE Study Group. (1993). Late assessment of thrombolysis efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction. Lancet, 342, 759-66.

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.